Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

NCT04663100 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia
Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Chronic Conditions

Interventions

OTHER: Patient-reported outcome measure
OTHER: Comprehensive Medication Review
OTHER: Pharmacist communication

Sponsor

University of Tennessee

Collaborators

[object Object]
[object Object]